HERON THERAPEUTICS, INC. /DE/ (HRTX) Operating Lease, Liability, Current USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary
Heron Therapeutics, Inc. /De/ quarterly Operating Lease, Liability, Current history and growth rate from 2019 to 2024.
  • Heron Therapeutics, Inc. /De/ Operating Lease, Liability, Current for the quarter ending March 31, 2024 was $3.14 M, a 13.6% increase year-over-year.
Operating Lease, Liability, Current, Quarterly (USD)
Operating Lease, Liability, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $3.14 M +$375 K +13.6% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $3.08 M +$381 K +14.1% Dec 31, 2023 10-Q 2024-05-07
Q3 2023 $3 M +$379 K +14.5% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $2.58 M +$31 K +1.22% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $2.76 M +$278 K +11.2% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $2.69 M +$277 K +11.5% Dec 31, 2022 10-K 2024-03-12
Q3 2022 $2.62 M -$631 K -19.4% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $2.55 M -$613 K -19.4% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $2.48 M -$597 K -19.4% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $2.42 M -$580 K -19.4% Dec 31, 2021 10-K 2023-03-29
Q3 2021 $3.25 M +$339 K +11.6% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $3.16 M +$332 K +11.7% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $3.08 M +$326 K +11.8% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $3 M +$1.07 M +55.6% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $2.91 M +$1.19 M +69.2% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $2.83 M +$1.11 M +64.3% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $2.76 M +$723 K +35.6% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $1.93 M Dec 31, 2019 10-K 2021-02-24
Q3 2019 $1.72 M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $1.72 M Jun 30, 2019 10-Q 2019-08-05
Q1 2019 $2.03 M Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.